Chargement en cours...
Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia
Treatment results for multiple myeloma and plasma cell leukemia have considerably improved, but cure remains elusive and establishing new therapeutic approaches constitutes a major unmet clinical need. We analyzed the anti-myeloma properties of the aza-anthracenedione pixantrone which has been succe...
Enregistré dans:
| Publié dans: | Ann Hematol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6848044/ https://ncbi.nlm.nih.gov/pubmed/31628518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-019-03797-6 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|